Replies to post #63033 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Fair enough, that will require more specific TIL and ALC count monitoring. The technology is already there to break down lymphocyte constituent makeup, and again, perhaps much will be learned from the TMZ usage covariate analysis as it relates to OS and PFS. Hopefully it is a straightforward correlation and predictable tipping point.